HHS secretary RFK Jr. said that he would “shut the revolving door to reestablish public trust” in the department.

As an FDA executive, Cavazzoni handed Pfizer, her former employer, a record-setting number of approved drugs in one year. And ...

Pfizer on Monday named the former head of the U.S. health regulator's drug evaluation unit, Patrizia Cavazzoni, as its chief medical officer, bringing back an industry veteran to lead its regulatory ...

Patrizia Cavazzoni, formerly the top regulator of the ... Cavazzoni was the head of the FDA’s Center for Drug Evaluation and Research (CDER), from 2020 until her departure in January.

After leaving the FDA, where she served as director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., is returning to her previous employer: Big Pharma Pfizer. After ...

Pfizer’s decision to hire Patrizia Cavazzoni, a former top drug regulator ... sector for its all-too-cozy relationship with the FDA, including its penchant for hiring former top FDA officials ...

The Senate hearing for FDA Commissioner nominee Marty Makary comes after President Trump's NIH pick, Jay Bhattacharya, was ...

Patrizia Cavazzoni was formerly director of the FDA’s Center for Drug Evaluation and Research (CDER) from 2020 until January, when she resigned just ahead of President Trump’s return to office.

Pfizer has appointed former Patrizia Cavazzoni, MD, former director of the FDA's Center for Drug Evaluation and Research, as its new chief medical officer, Bloomberg reported Feb. 24. Dr ...

Patrizia Cavazzoni, a former high-ranking Food and ... the company announced Monday. Cavazzoni led the FDA’s Center for Drug Evaluation and Research from 2021 until her departure in mid-January.

Patrizia Cavazzoni, formerly the top regulator of the ... Cavazzoni was the head of the FDA’s Center for Drug Evaluation and Research (CDER), from 2020 until her departure in January.